By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


VLST Corp. 

Seattle  Washington    U.S.A.
Phone: n/a Fax:



Start Up

Company News
VLST Corp., After Nine Years and $50 Million, Sells Assets and Winds Down 8/7/2013 6:44:02 AM
VLST Corp. Cuts Scientific Group as Focus Shifts to Clinical Trials 9/27/2012 8:38:36 AM
VLST Corp. Scoops Up Antibody for Cancer From Pfizer Inc. (PFE) 8/31/2012 7:23:49 AM
Theraclone Sciences, Inc. and VLST Corp. Creators Form V-Gene 1/27/2012 7:59:39 AM
VLST Corp. Appoints Brian Blackman as Vice President, Finance & Administration 6/13/2011 9:49:07 AM
AnaptysBio, Inc. Announces Collaboration with VLST Corp. to Generate Novel Antibody Therapeutics 4/5/2010 9:03:38 AM
VLST Corp. Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk A/S (NVO) Pipeline 12/22/2009 7:58:50 AM
VLST Corp. and Novo Nordisk, Inc. (NVO) Announce Collaboration Agreement to Develop Therapeutics for Autoimmune and Inflammatory Disorders 12/17/2008 6:26:35 AM
VLST Corp. Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer 7/2/2008 9:29:05 AM
VLST Corp. Announces Board and Executive Management Appointments 2/13/2008 11:55:33 AM